These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 38179655)

  • 61. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
    Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
    Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential.
    van Bree NFHN; Wilhelm M
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291792
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
    Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
    Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment.
    Melo V; Bremer E; Martin JD
    Front Cell Dev Biol; 2022; 10():908389. PubMed ID: 35712656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants.
    Gao F; You X; Yang L; Zou X; Sui B
    Int Rev Immunol; 2024; 43(5):280-308. PubMed ID: 38525925
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Managing the TME to improve the efficacy of cancer therapy.
    Bilotta MT; Antignani A; Fitzgerald DJ
    Front Immunol; 2022; 13():954992. PubMed ID: 36341428
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.
    Baldari S; Di Modugno F; Nisticò P; Toietta G
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230627
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects.
    Hang Y; Huang J; Ding M; Shen Y; Zhou Y; Cai W
    Int Immunopharmacol; 2024 Oct; 140():112820. PubMed ID: 39096874
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability.
    Roy AM; Iyer R; Chakraborty S
    Cell Rep Med; 2023 Sep; 4(9):101170. PubMed ID: 37652015
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironment.
    Bae S; Brumbaugh J; Bonavida B
    Genes Cancer; 2018 Mar; 9(3-4):87-100. PubMed ID: 30108680
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
    Ringquist R; Ghoshal D; Jain R; Roy K
    Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular insights into phytochemicals-driven break function in tumor microenvironment.
    Rana P; Shrama A; Mandal CC
    J Food Biochem; 2021 Sep; 45(9):e13824. PubMed ID: 34219240
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy.
    de Looff M; de Jong S; Kruyt FAE
    Front Immunol; 2019; 10():1530. PubMed ID: 31333662
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy.
    Henke E; Nandigama R; Ergün S
    Front Mol Biosci; 2019; 6():160. PubMed ID: 32118030
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures.
    Feng B; Wu J; Shen B; Jiang F; Feng J
    Cancer Cell Int; 2022 Apr; 22(1):166. PubMed ID: 35488263
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy.
    Das K; Mukherjee T; Shankar P
    Biomolecules; 2023 May; 13(6):. PubMed ID: 37371477
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment.
    Fridman ES; Ginini L; Gil Z
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.